European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu časopisecké články, pozorovací studie, práce podpořená grantem
PubMed
27324686
DOI
10.1002/ejhf.566
Knihovny.cz E-zdroje
- Klíčová slova
- Acute, Chronic, Heart failure, Outcomes, Registry, Survival,
- MeSH
- akutní nemoc MeSH
- ambulantní péče MeSH
- chronická nemoc MeSH
- hospitalizace MeSH
- kardiologie MeSH
- komorbidita MeSH
- lidé středního věku MeSH
- lidé MeSH
- mortalita * MeSH
- následné studie MeSH
- příčina smrti MeSH
- prospektivní studie MeSH
- registrace * MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- společnosti lékařské MeSH
- srdeční selhání krev epidemiologie patofyziologie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- pozorovací studie MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Evropa epidemiologie MeSH
AIMS: The European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT-R) was set up with the aim of describing the clinical epidemiology and the 1-year outcomes of patients with heart failure (HF) with the added intention of comparing differences between participating countries. METHODS AND RESULTS: The ESC-HF-LT-R is a prospective, observational registry contributed to by 211 cardiology centres in 21 European and/or Mediterranean countries, all being member countries of the ESC. Between May 2011 and April 2013 it collected data on 12 440 patients, 40.5% of them hospitalized with acute HF (AHF) and 59.5% outpatients with chronic HF (CHF). The all-cause 1-year mortality rate was 23.6% for AHF and 6.4% for CHF. The combined endpoint of mortality or HF hospitalization within 1 year had a rate of 36% for AHF and 14.5% for CHF. All-cause mortality rates in the different regions ranged from 21.6% to 36.5% in patients with AHF, and from 6.9% to 15.6% in those with CHF. These differences in mortality between regions are thought reflect differences in the characteristics and/or management of these patients. CONCLUSION: The ESC-HF-LT-R shows that 1-year all-cause mortality of patients with AHF is still high while the mortality of CHF is lower. This registry provides the opportunity to evaluate the management and outcomes of patients with HF and identify areas for improvement.
1st Cardiology Department Athens University Medical School Athens Greece
3rd Department of Medicine Faculty General Hospital Charles University Prague Czech Republic
Alexandria University Alexandria Egypt
ANMCO Research Centre Florence Italy
Athens University Hospital Attikon Athens Greece
Cardiology Department University Hospital 12 de Octubre Madrid Spain
Department of Cardiology General Hospital Celje Celje Slovenia
Department of Cardiology Lithuanian University of Health Sciences Kaunas Lithuania
Department of Cardiology Medical University Graz Austria
Department of Cardiology Medical University of Lodz Lodz Poland
Department of Heart Failure Transplantation National Cardiovascular Institute Bratislava Slovakia
Department of Internal Medicine Clinical Hospital Mostar Mostar Bosnia and Herzegovina
EURObservational Research Programme European Society of Cardiology Sophia Antipolis France
Heart Failure Unit Cardiac Department Guglielmo da Saliceto Hospital AUSL Piacenza Italy
Hôpital Lariboisière Université Paris Diderot Inserm 942 Paris France
Monash University Australia and University of Warwick Coventry UK
Pauls Stradins Clinical University Hospital Riga Latvia
Poriya Medical Centre and Faculty of Medicine Bar Ilan University Israel
Semmelweis University Heart Centre Budapest Hungary
Turkey Yüksek Ihtisas Hospital Cardiology Clinic Ankara Turkey
University Hospital Lozenets Sofia Bulgaria
University of Belgrade School of Medicine Department of Cardiology Clinical Centre of Serbia
Citace poskytuje Crossref.org
Characteristics and outcomes of patients admitted for acute heart failure in a single-centre study
